K221349

Substantially Equivalent

XPER Technology PREMIUM Pro Blood Glucose Monitoring System

Applicant: Taidoc Technology Corporation
Product code: PZI
Advisory panel: Clinical Chemistry
Date received: 2022-05-09
Decision date: 2024-11-19
Decision: Substantially Equivalent
Clearance type: Dual Track
Location: New Taipei City, TW

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.